LEADS TO DEVELOPMENT – new member
LEADS TO DEVELOPMENT offers consultancy, regulatory advice and operational management for the preclinical and non-clinical development of therapeutic products, together with clinical oversight.
Read morePierre Fabre to commercialize and distribute ATARA EBVALLO® (tabelecleucel)
Pierre Fabre to commercialize and distribute ATARA EBVALLO® (tabelecleucel)
Read moreAzurBio Pharma – new member
AzurBio Pharma is a new international pharmaceutical company developing products and activities in the area of pharma innovation and rare or serious diseases.
Read morePolyplus acquires Bio Elpida to strengthen GMP Fill and Finish capacity
Polyplus acquires Bio Elpida, a French biotechnology contract development and manufacturing (CDMO) company to strengthen the supply chain for GMP formulation and filling at Polyplus.
Read moreAriana Pharma in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results from a post hoc analysis of CY6463 first-in-human studies at the 2022 Clinical Trials On Alzheimer’s Disease (CTAD)
Ariana Pharma, a leading Artificial Intelligence (AI) drug development company, in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results from a post hoc analysis of CY6463 first-in-human studies at the 2022 Clinical Trials On Alzheimer’s Disease (CTAD) international conference held in San Francisco, USA.
Read more